Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

BACKGROUND/OBJECTIVE: Delays in times to surgery, chemotherapy, and radiotherapy impair survival in breast cancer patients. Neoadjuvant chemotherapy (NAC) confers equivalent survival to adjuvant chemotherapy (AC), but it remains unknown which approach facilitates faster initiation and completion of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Med
Hauptverfasser: Melchior, Nicole M., Sachs, Darren B., Gauvin, Gabrielle, Chang, Cecilia, Wang, Chihsiung E., Sigurdson, Elin R., Daly, John M., Aggon, Allison A., Hayes, Shelly B., Obeid, Elias I., Bleicher, Richard J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Clinical Cancer Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163083/
https://ncbi.nlm.nih.gov/pubmed/32096915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2912
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge